Literature DB >> 15392563

Proteolytic enzymes; further studies on protein, polypeptide, and other inhibitors of serum proteinase, leucoproteinase, trypsin, and papain.

D GROB.   

Abstract

1. Serum proteinase precursor was found in plasma protein fractions I and III of Cohn. Inhibitors of serum proteinase, leucoproteinase, trypsin, and papain were found in fractions IV-1 and IV-4, and to a lesser extent in fractions V and I. 2. Pancreatic, soy bean, lima bean, and egg white inhibitors inhibited trypsin stoichiometrically. Pancreatic inhibitor had comparable inhibitory activity against serum proteinase; soy bean inhibitor had somewhat less, lima bean inhibitor even less, and egg white inhibitor very little. None of these inhibitors appreciably inhibited leucoproteinase or papain. 3. Serum and fractions IV - 1 and IV - 4 had marked inhibitory activity against trypsin and leucoproteinase, and somewhat less against serum proteinase and papain. The inhibitory activity of the plasma proteins against trypsin and leucoproteinase was due almost entirely to fractions IV - 1 and IV - 4; against serum proteinase and papain fraction V was slightly more important. The "reconstituted plasma proteins" accounted for 8 to 25 per cent of the proteinase-inhibitory activity of whole serum or plasma. 4. The proteinase-inhibitory activity of serum, plasma protein fractions, and soy bean inhibitor was heat labile, while that of pancreatic, lima bean, and egg white inhibitors was relatively heat stable. 5. Reducing and oxidizing agents, in very high concentration, inhibited serum proteinase, as well as trypsin and leucoproteinase. These proteinases were not influenced by mercurial sulfhydryl inhibitors, indicating that free sulfhydryl groups do not play an important part in their activity.

Entities:  

Keywords:  BLOOD; ENZYMES

Mesh:

Substances:

Year:  1949        PMID: 15392563      PMCID: PMC2147146          DOI: 10.1085/jgp.33.2.103

Source DB:  PubMed          Journal:  J Gen Physiol        ISSN: 0022-1295            Impact factor:   4.086


  8 in total

1.  The skin protease inhibitory factor of plasma.

Authors:  A Beloff
Journal:  Biochem J       Date:  1946       Impact factor: 3.857

2.  STUDIES IN BLOOD COAGULATION: THE COAGULATION PROPERTIES OF CERTAIN GLOBULIN FRACTIONS OF NORMAL HUMAN PLASMA IN VITRO.

Authors:  F H Taylor; C S Davidson; H J Tagnon; M A Adams; A H Macdonald; G R Minot
Journal:  J Clin Invest       Date:  1945-09       Impact factor: 14.808

3.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XV. THE PROTEINS CONCERNED IN THE BLOOD COAGULATION MECHANISM.

Authors:  J T Edsall; R M Ferry; S H Armstrong
Journal:  J Clin Invest       Date:  1944-07       Impact factor: 14.808

4.  A NEW BLOOD-CLOTTING THEORY.

Authors:  J H Ferguson
Journal:  Science       Date:  1943-04-09       Impact factor: 47.728

5.  Activity curves of crude and purified inhibitors and accelerators of blood coagulation.

Authors:  L M TOCANTINS; R T CARROLL
Journal:  Proc Soc Exp Biol Med       Date:  1948-12

6.  THE SIGNIFICANCE OF BIOCHEMICAL UNITS IN INFLAMMATORY EXUDATES.

Authors:  V Menkin
Journal:  Science       Date:  1945-04-27       Impact factor: 47.728

7.  INHIBITION OF beta HEMOLYTIC STREPTOCOCCI FIBRINOLYSIN BY TRYPSIN INHIBITOR (ANTIPROTEASE).

Authors:  I A Mirsky
Journal:  Science       Date:  1944-09-01       Impact factor: 47.728

8.  BIOCHEMICAL STUDIES ON THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI : I. ISOLATION AND CHARACTERIZATION OF FIBRINOLYSIN.

Authors:  R L Garner; W S Tillett
Journal:  J Exp Med       Date:  1934-07-31       Impact factor: 14.307

  8 in total
  14 in total

1.  Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. II. Isolation and properties of the permeability factor and its inhibitor.

Authors:  D L WILHELM; A A MILES; M E MACKAY
Journal:  Br J Exp Pathol       Date:  1955-02

2.  Biochemical and morphological studies of radiation injury in tissue culture: a comparison with cellular injury in antigen-antibody reactions.

Authors:  H HAYASHI; A TOKUDA; T ONO; Y TAKABA
Journal:  Br J Exp Pathol       Date:  1963-02

3.  Pancreatic trypsin inhibitor. II. Reaction with trypsin.

Authors:  N M GREEN; E WORK
Journal:  Biochem J       Date:  1953-05       Impact factor: 3.857

Review 4.  Regulation of lysosomal enzyme secretion: role in inflammation.

Authors:  L J Ignarro
Journal:  Agents Actions       Date:  1974-10

5.  Studies of the plasmin system. III. Physical properties of the two plasmin inhibitors in plasma.

Authors:  P S NORMAN; B M HILL
Journal:  J Exp Med       Date:  1958-11-01       Impact factor: 14.307

6.  The activation of staphylococcal free coagulase by plasma constituents and the hydrolysis of Nalpha-toluene-p-sulphonyl-L-arginine methyl ester (TAME) by activated coagulase.

Authors:  G HAUGHTON; E S DUTHIE
Journal:  Biochem J       Date:  1959-02       Impact factor: 3.857

7.  Studies on the inhibition of proteolytic enzymes by serum. II. Demonstration that separate proteolytic inhibitors exist in serum; their distinctive properties and the specificity of their action.

Authors:  N R SHULMAN
Journal:  J Exp Med       Date:  1952-06       Impact factor: 14.307

8.  Biochemical aspects of pancreatitis.

Authors:  H BUSCH
Journal:  Yale J Biol Med       Date:  1957-06

9.  Studies on serum proteolytic enzyme inhibition; effect of tissue destruction, cortisone acetate, and splenectomy on the serum trypsin inhibitor.

Authors:  F C MOLL
Journal:  J Exp Med       Date:  1956-03-01       Impact factor: 14.307

10.  Studies of the plasmin system. II. Inhibition of plasmin by serum or plasma.

Authors:  P S NORMAN
Journal:  J Exp Med       Date:  1958-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.